DermDox Group Expands with Acquisition of NEPA Centers

DermDox Group Expands Its Reach in Healthcare Services
In a strategic move to enhance its offerings, DermDox, a frontrunner in providing exceptional medical, surgical, and aesthetic services, has taken a significant step by acquiring the Dermatology Centers of NEPA. This expansion increases their number of locations from eight to ten, reinforcing their commitment to excellence in healthcare.
New Additions to the DermDox Family
The acquisition includes two key locations that will be rebranded under the DermDox name. The facilities, located in Wilkes-Barre and Berwick, are set to boost access to high-quality dermatological services for a growing patient base in the area. The new practices are located at:
New Facility Locations
150 Mundy Street, Wilkes-Barre, PA 18702
1016 W. Front Street, Berwick, PA 18603
Enhancing Patient Care
With these additions, DermDox is positioned to serve nearly 120,000 patients across its ten locations. The inclusion of Dr. Christopher Snyder and PA-C Brooke Casey highlights the company’s emphasis on reputable and skilled healthcare providers. They will continue to offer a range of services designed to meet the diverse needs of their patients.
Mission-Driven Services
DermDox Group is dedicated to delivering the highest quality of care in a personable setting. Their mission revolves around compassionate service, striving to establish trusting relationships between patients and providers. By embracing innovative models, they promote access and facilitate important healthcare communication for all patients.
Looking Ahead
With this strategic acquisition, DermDox Group not only expands its geographical footprint but also strengthens its ability to provide comprehensive dermatological care. Their commitment to quality services and patient satisfaction remains at the forefront of their operations as they integrate the new centers within their established brand.
Patients looking for a full range of dermatological services or to schedule appointments can easily access information about DermDox Centers and the services offered, ensuring community members have the resources they need for their healthcare journey.
Frequently Asked Questions
What is DermDox Group?
DermDox Group is a leading provider of medical, surgical, and aesthetic services in the field of dermatology.
Where are the new Dermatology Centers located?
The new centers are located in Wilkes-Barre and Berwick, Pennsylvania.
How many locations does DermDox Group currently operate?
After the acquisition, DermDox Group operates ten locations across the region.
What services does DermDox offer?
DermDox provides a variety of dermatological services, including medical consultations, surgical procedures, and aesthetic treatments.
How can patients learn more or schedule an appointment?
Patients can find more information by visiting the DermDox website to view services and schedule appointments.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.